| Cheryl A Opalack, DO | |
|
32 Sapling Drive, Kennett Square, PA 19348 | |
| (610) 388-3190 | |
| (610) 388-3191 |
| Full Name | Cheryl A Opalack |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 32 Sapling Drive, Kennett Square, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598773442 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | OS003388L (Pennsylvania) | Primary |
| 208D00000X | General Practice | OS003388L (Pennsylvania) | Secondary |
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
Urgent Matters, Philips Blue Jay Consulting, and Schumacher Clinical Partners are pleased to announce the winners of the Emergency Care Innovation of the Year Award, a competition to foster innovation in emergency departments nationwide.
Merck, known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for suvorexant, the company's investigational insomnia medicine, has been accepted for standard review by the U.S. Food and Drug Administration (FDA).
Birth defects remain a leading cause of death in the first year of life. According to the March of Dimes, every 3 to 4 minutes a baby is born with a birth defect in the United States. About 1 in every 33 infants is affected by birth defects.
A cautious, measured approach to relaxation of lockdown measures is required to protect the most vulnerable members of society and support the health service, a team of infectious disease experts from the University of Warwick, who have investigated the impact of current lockdown measures upon the spread of COVID-19 in the UK, has found.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cheryl A Opalack, DO 154 Exton Square Mall, Exton, PA 19341-2440 Ph: (484) 421-1669 | Cheryl A Opalack, DO 32 Sapling Drive, Kennett Square, PA 19348 Ph: (610) 388-3190 |
News Archive
Urgent Matters, Philips Blue Jay Consulting, and Schumacher Clinical Partners are pleased to announce the winners of the Emergency Care Innovation of the Year Award, a competition to foster innovation in emergency departments nationwide.
Merck, known as MSD outside the United States and Canada, today announced that the New Drug Application (NDA) for suvorexant, the company's investigational insomnia medicine, has been accepted for standard review by the U.S. Food and Drug Administration (FDA).
Birth defects remain a leading cause of death in the first year of life. According to the March of Dimes, every 3 to 4 minutes a baby is born with a birth defect in the United States. About 1 in every 33 infants is affected by birth defects.
A cautious, measured approach to relaxation of lockdown measures is required to protect the most vulnerable members of society and support the health service, a team of infectious disease experts from the University of Warwick, who have investigated the impact of current lockdown measures upon the spread of COVID-19 in the UK, has found.
› Verified 1 days ago